P1675: SUTIMLIMAB PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: OPEN-LABEL EXTENSION OF THE PHASE 3 CADENZA STUDY

ABSTRACT:

SUBMITTER: Roth A 

PROVIDER: S-EPMC10430149 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature